ABL1 and leukemia: Our experimental results showed that the compound ZINC21710815 inhibits the proliferation of leukemia cells, inhibits cell cycle, induces autophagy and apoptosis and inhibits the tyrosine phosphorylation of BCR-ABL target protein and downstream proteins.